About Us Overview and History

Overview

  • Name

    CiRA Foundation

  • Founder

    Kyoto University

  • Since

    The foundation was originally founded as a general incorporated foundation on September 6, 2019, but then registered as a public interest incorporated foundation by the Cabinet Office on April 1, 2020.

  • Postal
    Address

    53 Shogoin kawahara-cho, Sakyo-ku, Kyoto 606-8397, Japan.

  • Our services
    • Cell manufacturing, quality evaluation, cell storage management and cell production management
    • Research and development
    • Support for clinical application
    • Training and human resources development
    • Information sharing and information transmission through industry-government-academia exchange at the national and international levels

History

April 1, 2010

Facility for iPS Cell Therapy (FiT1) is completed at the Center of
iPS Cell Research and Application (CiRA), Kyoto University.

June 12, 2013

The Japanese Red Cross Society starts collecting platelet blood donations
in Osaka and Kyoto for iPS cell research purposes.

May 13, 2015

FiT is recognized as the Cell Processing Center based on
the Japan Act on Securement of Safety of Regenerative Medicine.
Facility number:FA5150001

August 6, 2015

The iPS Cell Stock is launched.

April 18, 2016

The Japanese Red Cross and Japan Marrow Donor Program begin recruiting
bone marrow donors for iPS cell research purposes.

February 17, 2017

A second Facility for iPS Cell Therapy (FiT2) is completed at CiRA.

January 11, 2018

FiT 1 and FiT 2 are recognized as the Cell Processing Center based on
the Japan Act on Securement of Safety of Regenerative Medicine.
Facility number:FA5170003

September 6, 2019

The foundation is founded as a general incorporated foundation.

April 1, 2020

The foundation is registered as a public interest incorporated foundation
by the Cabinet Office.

April 1, 2020

FiT 1 and FiT 2 are recognized as the Cell Processing Center based on
the Japan Act on Securement of Safety of Regenerative Medicine.
Facility number:FA5200001

January 15, 2021

Obtained manufacturing license based on the PMD Act
License number:26FZ110001

Related Information

For Public
Significance
For Researchers and Companies
iPS Cell Stock Project